InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
MDP | Determining the metabolic impact of postbiotics in mice. | 2022 | STAR Protoc. | Anhê F.F. et al. | DOI: 10.1016/j.xpro.2021.101098 |
LPS-EB (LPS from E. coli O111:B4) | Determining the metabolic impact of postbiotics in mice. | 2022 | STAR Protoc. | Anhê F.F. et al. | DOI: 10.1016/j.xpro.2021.101098 |
iE-DAP | Determining the metabolic impact of postbiotics in mice. | 2022 | STAR Protoc. | Anhê F.F. et al. | DOI: 10.1016/j.xpro.2021.101098 |
LPS-RS | Determining the metabolic impact of postbiotics in mice. | 2022 | STAR Protoc. | Anhê F.F. et al. | DOI: 10.1016/j.xpro.2021.101098 |
C14-Tri-LAN-Gly | Determining the metabolic impact of postbiotics in mice. | 2022 | STAR Protoc. | Anhê F.F. et al. | DOI: 10.1016/j.xpro.2021.101098 |
LPS-PG (Lipopolysaccharide from P. gingivalis) | Determining the metabolic impact of postbiotics in mice. | 2022 | STAR Protoc. | Anhê F.F. et al. | DOI: 10.1016/j.xpro.2021.101098 |
R848 VacciGrade™ | Celastrol gel ameliorates imiquimod-induced psoriasis-like dermatitis in mice... | 2022 | Biomed Pharmacother | Liu L. et al. | DOI: 10.1016/j.biopha.2022.112644 |
Puromycin | The deubiquitinase Usp27x as a novel regulator of cFLIP L protein expression ... | 2022 | Apoptosis | Dold M.N. et al. | DOI: 10.1007/s10495-021-01706-9 |
HKMT | Identification of anti-lipoarabinomannan antibodies against mannan core and t... | 2022 | Tuberculosis (Edinb) | Nakayama H. et al. | DOI: 10.1016/j.tube.2022.102165 |
QUANTI-Blue™ | TNF-α response in macrophages depends on clinical Legionella pneumophila isol... | 2022 | Virulence | Guillemot J. et al. | DOI: 10.1080/21505594.2021.2022861 |
THP1-Blue™ NF-κB Cells | TNF-α response in macrophages depends on clinical Legionella pneumophila isol... | 2022 | Virulence | Guillemot J. et al. | DOI: 10.1080/21505594.2021.2022861 |
CL097 | Innate immune deficiencies are associated with severity and poor prognosis in... | 2022 | Sci Rep | Peyneau M. et al. | DOI: 10.1038/s41598-021-04705-7 |
Normocin® - Antimicrobial Reagent | Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. | 2021 | Nature | Carreño J.M. et al. | DOI: 10.1038/s41586-022-04399-5 |
Puromycin | Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. | 2021 | Nature | Carreño J.M. et al. | DOI: 10.1038/s41586-022-04399-5 |
Puromycin | The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and al... | 2022 | Cell Mol Life Sci | Schreiber A. et al. | DOI: 10.1007/s00018-021-04085-1 |
Bafilomycin A1 | Pharmacological agents targeting autophagy and their effects on lipolysis in ... | 2022 | Mol Cell Endocrinol | Xu Q. et al. | DOI: 10.1016/j.mce.2022.111555 |
3-Methyladenine | Pharmacological agents targeting autophagy and their effects on lipolysis in ... | 2022 | Mol Cell Endocrinol | Xu Q. et al. | DOI: 10.1016/j.mce.2022.111555 |
TLR4-based adjuvant - MPLA-SM VacciGrade™ | Soluble antigens derived from Coxiella burnetii elicit protective immunity in... | 2021 | Cell Rep Med | Gregory A.E. et al. | DOI: 10.1016/j.xcrm.2021.100461 |
ODN 1826 - TLR9 ligand | Soluble antigens derived from Coxiella burnetii elicit protective immunity in... | 2021 | Cell Rep Med | Gregory A.E. et al. | DOI: 10.1016/j.xcrm.2021.100461 |
Quil-A® adjuvant | Soluble antigens derived from Coxiella burnetii elicit protective immunity in... | 2021 | Cell Rep Med | Gregory A.E. et al. | DOI: 10.1016/j.xcrm.2021.100461 |